Corcept Therapeutics | CORT - Ordinary Share Capital


Corcept Therapeutics reported $105.12M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Acadia Pharmaceuticals USD 168.71M 104K Sep/2025
Alaunos Therapeutics USD 2.21M 2.2M Sep/2025
ANI Pharmaceuticals USD 21.73M 21.73M Jun/2025
Ardelyx USD 238.02M 1.13M Dec/2024
Assertio Holdings USD 9K 0 Dec/2023
Aurora Cannabis CAD 6.98B 907K Dec/2024
BioMarin Pharmaceutical USD 192.1M 97K Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Canopy Growth CAD 332.38M 127.23M Sep/2025
Corcept Therapeutics USD 105.12M 164K Sep/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Esperion Therapeutics USD 112K 11K Sep/2023
J&J USD 2.41B 584K Sep/2025
Knight Therapeutics CAD 539.32M 1.63M Sep/2024
Merck USD 2.49B 15.79M Sep/2025
Nektar Therapeutics USD 19K 0 Sep/2024
Novartis USD 1.94B 23.4M Jun/2025
Novartis USD 1.92B 17.06M Sep/2025
Omeros USD 611K 17K Dec/2023
Pacira USD 44.9M 44.85M Jun/2025
Pfizer USD 5.69B 1000K Sep/2025
Supernus Pharmaceuticals USD 57.12M 1000K Sep/2025
TG Therapeutics USD 155.21M 2.81M Sep/2025